Article
The University of Chicago Cancer Center Awarded Nearly 4 Million by the NCI
University of Chicago's Comprehensive Cancer Center received $3.9 million from the NCI as the Lead Academic Participating Site for the new NCTN initiative.
A team from the University of Chicago Medicine Comprehensive Cancer Center has received a five-year, $3.9-million award from the National Cancer Institute to serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN). The University of Chicago team received the best possible score in the highly competitive application process.
The new network is designed to improve the speed and efficiency of cancer clinical trials, according to the National Cancer Institute. The NCTN -- which will focus on early and late stage clinical trials for adults with cancer -- will consist of fewer but larger groups of investigators and will distribute resources in a more effective way.
Read the press release here:
Source: University of Chicago
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
